Fig. 7From: Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19Safety evaluation of CR3022/B38 NVs. a The cell viability of L02 cells or HK-2 cells co-cultured with CR3022/B38 NVs was measured by CCK-8 assay. b Body weight curves of the mice treated with CR3022/B38 NVs or PBS. c H&E stained histological sections of the heart, liver, spleen, lung, and kidney from mice treated with CR3022/B38 NVs or PBS. Scale bar: 100 μmBack to article page